- Home
- PULM vs FCUV Comparison
PULM vs FCUV Comparison
Compare PULM & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- FCUV
- Stock Information
- Founded
- PULM 2003
- FCUV 2012
- Country
- PULM United States
- FCUV United States
- Employees
- PULM N/A
- FCUV N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- PULM Health Care
- FCUV Industrials
- Exchange
- PULM Nasdaq
- FCUV Nasdaq
- Market Cap
- PULM 33.2M
- FCUV 27.6M
- IPO Year
- PULM N/A
- FCUV N/A
- Fundamental
- Price
- PULM $7.43
- FCUV $3.67
- Analyst Decision
- PULM
- FCUV
- Analyst Count
- PULM 0
- FCUV 0
- Target Price
- PULM N/A
- FCUV N/A
- AVG Volume (30 Days)
- PULM 34.2K
- FCUV 15.0K
- Earning Date
- PULM 08-12-2025
- FCUV 08-13-2025
- Dividend Yield
- PULM N/A
- FCUV N/A
- EPS Growth
- PULM N/A
- FCUV N/A
- EPS
- PULM N/A
- FCUV N/A
- Revenue
- PULM $1,921,000.00
- FCUV $408,887.00
- Revenue This Year
- PULM N/A
- FCUV N/A
- Revenue Next Year
- PULM $134.88
- FCUV N/A
- P/E Ratio
- PULM N/A
- FCUV N/A
- Revenue Growth
- PULM N/A
- FCUV 6.49
- 52 Week Low
- PULM $1.78
- FCUV $1.50
- 52 Week High
- PULM $10.40
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- PULM 49.28
- FCUV 40.87
- Support Level
- PULM $8.49
- FCUV $3.58
- Resistance Level
- PULM $8.75
- FCUV $3.78
- Average True Range (ATR)
- PULM 0.42
- FCUV 0.23
- MACD
- PULM -0.14
- FCUV -0.01
- Stochastic Oscillator
- PULM 0.11
- FCUV 25.95
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.